External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
about
Recombinant Newcastle disease virus as a vaccine vector for cancer therapySafety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvantRadiotherapy combination opportunities leveraging immunity for the next oncology practiceNK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer ImmunotherapyMetastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapyTherapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advancesCombination regimens of radiation therapy and therapeutic cancer vaccines: mechanisms and opportunitiesRadiation for Awakening the Dormant Immune System, a Promising Challenge to be ExploredThe effect of radiation on the immune response to cancersUnlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapyRadiation meets immunotherapy - a perfect match in the era of combination therapy?Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccinesTargeting and utilizing primary tumors as live vaccines: changing strategiesCombining radiotherapy and cancer immunotherapy: a paradigm shiftThe optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translationRecent advances in therapeutic cancer vaccinesRadiation as immunomodulator: implications for dendritic cell-based immunotherapyThe efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunityVariant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell linesAn in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapyTumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated KillingImmunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implicationsRadiovaccination Hypothesis.Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.Adoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.Vaccines against human carcinomas: strategies to improve antitumor immune responses.Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancerAntitumor immunity induced after α irradiationDifferential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation.Vaccines as monotherapy and in combination therapy for prostate cancer.Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways.Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.The tumor-immune microenvironment and response to radiation therapyDual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine.Dual roles for immune metagenes in breast cancer prognosis and therapy prediction.Combinations of immunotherapy and radiation in cancer therapy.Prostate cancer as a model for tumour immunotherapy.
P2860
Q24602728-8B8B89F9-A0BC-4956-9971-171ED039DA0CQ24655036-9C7887A5-FF2F-4F1F-A92C-BD2DEFF40605Q26738443-3688A07A-9953-4D6D-AC78-9B79D2EEBAD4Q26797345-83F3EFEA-8D94-49E8-89C7-0A475DEE308BQ26825053-F0FD1A9C-CFFE-41FC-8DB2-D1F14AC1C2CBQ26827475-DE02D64D-84DF-40D9-A235-1836B2A76717Q26851710-EF7B3831-513F-4F8E-97C9-B9BBD7267154Q26865395-5ADDB41E-90B2-4F6D-AFD1-7468DC855316Q26995372-44A8A61A-EC0A-42D7-8563-5264923FE34FQ27001216-E63B2E91-882B-4A16-B6D9-6A599F06DF8CQ27005913-260DD683-1036-4B0D-AA9F-BFD60C4AE8D1Q27008070-C39AA0B8-E7E6-4B08-AF65-FB8627745404Q27009348-0505AB59-189E-4551-82DE-577F05CBFD81Q27021428-96CDD224-E152-45D0-8257-12633EE525A9Q27024106-A14ACBAC-55A6-4754-9319-06B80B252D95Q27025266-990B9991-89FB-4FDC-8C17-AB44B65143AAQ27025756-45CD9FDD-52BB-4F10-9545-3A90304BE42FQ28304923-8F74760D-BCC6-4B62-8B0B-10453D33A807Q28672938-F4D21B75-5BBB-46CF-B7AE-09C1B7A1E117Q28729093-3FDE5856-7228-4AB4-A656-3D15A2258F6AQ33275987-C2D9FD29-5FA1-4ADE-8C61-71464EAF311BQ33621393-9DF2D783-ED0D-4A37-A77F-77C6012F53C4Q33638639-78762073-2A23-45F7-950A-194314D7D151Q33703387-D619BDD4-413E-4BA5-8F7C-52DD36F7BFD9Q33713511-1EBEB525-DD60-473B-8BFE-B67B662328D8Q33734281-89F455FE-7319-49E2-962A-ECDE5F354AC1Q33871724-ABF0B8C7-0345-44FA-8966-ADB16F848512Q33891246-936BB242-EEED-4EEE-B5AD-9523D598E364Q33911452-631F01E5-12E5-4D0B-83FC-5EC9BF6A19CDQ34039068-AE51444B-1747-416F-B9A6-9DD451118708Q34184469-B4BDC60F-C926-4EAD-94D3-C298C9CF789DQ34313298-C40E2C09-2A86-4B7B-AD09-480724ACFB2DQ34326006-43783509-2C31-44F4-A26F-37FD01628C7FQ34333155-DA193497-76B6-4AE2-9BF2-6E3E8A9A5E59Q34438000-A307B18A-4533-4177-A60F-F06CDB38A5FAQ34444598-8BFC4454-7E44-4F24-8BF0-3E2387E8017EQ34537725-B111E068-7541-48FE-AD7A-739DA1B5F99CQ34558758-97B26163-2E68-485B-831C-E15DD63F2099Q34582640-9A55385C-766B-4777-B308-A6890D1FAE7CQ34856875-381AD183-4596-46A3-9719-F9A63BBF3AF9
P2860
External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
External beam radiation of tum ...... ccine-mediated T-cell killing.
@en
type
label
External beam radiation of tum ...... ccine-mediated T-cell killing.
@en
prefLabel
External beam radiation of tum ...... ccine-mediated T-cell killing.
@en
P2093
P1433
P1476
External beam radiation of tum ...... ccine-mediated T-cell killing.
@en
P2093
C Norman Coleman
James W Hodge
Jeffrey Schlom
Kevin Camphausen
Mala Chakraborty
Scott I Abrams
P304
P356
10.1158/0008-5472.CAN-04-0073
P407
P577
2004-06-01T00:00:00Z